Skip to main content
. 2014 Dec 30;6(5):2951–2965. doi: 10.18632/oncotarget.3095

Figure 3. CD44 functions upstream of ERK, AKT and Hippo-YAP pathways.

Figure 3

(A) CD44 siRNA affects both mRNA and protein levels. (B-C) CD44 silencing inactivates the (B) ERK and (C)AKT pathways. (D-E) CD44 silencing inactivates YAP without affecting the nuclear-to-cytoplasmic translocation of YAP after the cells reach confluence. (F) CD44 silencing activates tumor suppressor function of NF2. (G) CD44 silencing activates tumor suppressor function of LATS1/2 not MST1/2. *p<0.05.

HHS Vulnerability Disclosure